This page shows the latest European Union news and features for those working in and with pharma, biotech and healthcare.
With a total budget of 2.4bn, the IHI is a public-private partnership between the European Union (EU) and Europe’s life sciences industries aiming to translate health research and
Pressure on COVID-19 vaccine manufacturers is being mounted as European Union (EU) governments are in a push to renegotiate contracts, with a caution issued by EU officials that millions of ... to the European Union might end up being disposed of".
Evusheld has marketing authorisation in the European Union and was granted conditional marketing authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK for pre-exposure prophylaxis of
The winners of the first ‘neurotechprize’ have been announced by EIT Health, part of the European Institute of Innovation and Technology (EIT), a branch of the European Union, and Biogen.
Multiple regulatory authorities are reviewing submissions for Ultomiris for the treatment of gMG, including those in the European Union (EU) and Japan.
New pledges from the European Federation of Pharmaceutical Industries and Associations (EFPIA) member companies may increase the availability of innovative medicines throughout EU countries. ... and 46% on average in the European Union.
More from news
Approximately 10 fully matching, plus 333 partially matching documents found.
Precipice of change. The European Institute of Innovation and Technology (EIT), a not-for-profit catalyst co- funded by the European Union, believes that bringing people together is a key component
Furthermore, the disease expertise and specialist skills that are required may not be widely available in every European country. ... There’s a real opportunity for the European Union to act as a ‘one-stop shop’ to increase process transparency and
This was the first trade deal reached by the United Kingdom following its departure from the European Union. ... Perhaps unsurprisingly, London is the most popular European city for Japanese residents to live in overseas and therefore gives a clear
risks. The ongoing and unprecedented public health crisis caused by COVID-19 has overstretched the structures and mechanisms of the European Union, especially those that deal with emergencies. ... Due to its financial innovation, not only does it
In the European Union, the Orphan Drug Regulation was adopted in 2000. ... Support success. According to Lavinia Meloni, spokeswoman for the European Federation of Pharmaceutical Industries and Associations, efforts to encourage development of drugs for
More from intelligence
Approximately 1 fully matching, plus 47 partially matching documents found.
Dr Hoerr said: “It is a tremendous honor to be selected by the European Commission as member of the High Level Group focused on advancing innovation throughout the European Union. ... Governing board member of the European Institute for Innovation and
Lisa will play a leading role as we negotiate the future of our industry outside the European Union and as we work with government to build an industrial strategy with
Andreas Walter brings experience from the EFPIA. The European Medicines Verification Organisation (EMVO) has appointed Andreas Walter as its general manager. ... It was established last year by industry organisations, including EFPIA, and the European
The European Medicines Verification Organisation (EMVO) has appointed Sonia Ruiz Moran as its new president, replacing John Chave, former secretary general of Pharmaceutical Group of the European Union (PGEU). ... She said: “The planning and design of
De Garidel has been chairman and CEO of Ipsen, which specialises in neurology, endocrinology and urology-oncology, since 2010 and he chaired the European Biopharmaceutical Enterprises Association from 2010-12. ... The IMI is a public-private partnership
More from appointments
Approximately 0 fully matching, plus 11 partially matching documents found.
Greater clarity around nanomedicines in the revised pharmaceutical legislation should not only be regarded as a necessary next step to ensure patient safety and promote innovation by the European Union, but ... The European Union has the chance to set a
However, the passing of the Orphan Drug Act by the FDA in 1983 and the reciprocal Orphan Drug Regulation by the European Union in 1999 has helped to incentivise drug development
France is the second largest economy in the European Union and one of the largest consumers of pharmaceutical products in the world. ... As a member of the network, PRPA will work collaboratively alongside London-based European hub partner Aurora
On Wednesday 16th September, Ursula Von Der Leyen, President of the European Union, announced in her State of Union address that they plan to develop BARDA, a Biomedical Advanced Research and
HIGHLIGHTS INCLUDE:. Opportunities and threats of digital therapeutics after COVID-19. Digital therapeutics landscape in the European Union.
More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.
Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...